Lopinavir and Ritonavir
Links shared publicly online about this topic
Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir–ritonavir - Puech - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library
onlinelibrary.wiley.com — “Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir–ritonavir - Puech - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 12, 2011 at 4:36 am By:
Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV postâ€*exposure prophylaxis c... http://bit.ly/fCBcyA
Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir–ritonavir - Puech - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library
onlinelibrary.wiley.com — “Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir–ritonavir - Puech - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 11, 2011 at 9:59 pm By:
Drugs and Devices OW OW Health
Extreme bradycardia due to multiple drug–drug interactions in a patient with HIV postâ€*exposure prophylaxis c... http://bit.ly/fCBcyA
ingentaconnect Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF...
ingentaconnect.com — “ingentaconnect Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF...” View full resource at ingentaconnect.com
Most Recently Shared on May 11, 2011 at 8:37 pm By:
Orlistat/lopinavir/ritonavir interaction: Decreased lopinavir CSF concentration, leading to HIV-related meningo-... http://bit.ly/iPYKOe
FDA Alert: Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies
drugs.com — “FDA Alert: Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies” View full resource at drugs.com
Most Recently Shared on March 8, 2011 at 11:11 pm By:
Drugs and Devices OW OW Health
Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies: Audience: Infect... http://bit.ly/egUErs #FDA
FDA Alert: Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies
drugs.com — “FDA Alert: Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies” View full resource at drugs.com
Most Recently Shared on March 9, 2011 at 12:19 am By:
FDA Alert - Label Change: Kaletra (lopinavir/ritonavir) - Serious Health Problems in Premature Babies - http://bit.ly/gwAhTi
Kaletra (Lopinavir/Ritonavir) Package Insert Revision Regarding Drug-Drug Interaction Information - The Body
thebody.com — “On January 29, 2009, FDA approved revisions to the Kaletra (lopinavir/ritonavir) package insert to include drug-drug interaction information for ...” View full resource at thebody.com
Most Recently Shared on February 4, 2010 at 1:02 am By:
Kaletra (Lopinavir/Ritonavir) Package Insert Revision Regarding Drug-Drug Interaction Information http://is.gd/7BR8I #hiv #aids #kaletra
Kaletra (Lopinavir/Ritonavir) Oral Solution Label Changes Related to Toxicity in Preterm Neonates - The Body
thebody.com — “On February 24, 2011, FDA approved changes to the Kaletra (lopinavir/ritonavir) Oral Solution product label related to toxicity in preterm neonates ...” View full resource at thebody.com
Most Recently Shared on February 28, 2011 at 8:01 pm By:
Kaletra (Lopinavir/Eitonavir) Oral Solution Label Changes Related to Toxicity in Preterm Neonates http://bit.ly/fdQcqs #hiv #aids #infants
Abbott Receives European Approval for Once-Daily Dosing of Kaletra (lopinavir/ritonavir) Tablet: September 14, 2009
abbott.com — “Abbott Receives European Approval for Once-Daily Dosing of Kaletra (lopinavir/ritonavir) Tablet” View full resource at abbott.com
Most Recently Shared on September 14, 2009 at 10:10 am By:
eyeonfda Pharma and Health Lawyer
Abbott Gets Euro Approval for 1x-Daily Dosing of Kaletra® (lopinavir/ritonavir) http://bit.ly/BYXeG
Lopinavir/ritonavir (Kaletra) Monotherapy May Be Hazardous for Patients with a History of Low CD4 Cell Counts
hivandhepatitis.com — “CROI 2009 - HIV and Hepatitis.com CROI 2009 Conference Highlights” View full resource at hivandhepatitis.com
Most Recently Shared on March 25, 2009 at 11:13 pm By:
Peter Schick Health Organization
Lopinavir/ritonavir (Kaletra) Monotherapy May Be Hazardous for Patients with a History of Low CD4 Cell Counts http://bit.ly/6VPd
ingentaconnect LopinavirRitonavir: A Review of its Use in the Management of HIV-...
ingentaconnect.com — “ingentaconnect LopinavirRitonavir: A Review of its Use in the Management of HIV-...” View full resource at ingentaconnect.com
Most Recently Shared on September 17, 2010 at 6:05 pm By:
Drugs and Devices OW OW Health
LopinavirRitonavir: A Review of its Use in the Management of HIV-1 Infection: (Source: Drugs) http://bit.ly/d4g3qH
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra ( lopinavir / ritonavir ) for Treatment-Experienced Patients: April 28, 2010
abbott.com — “Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra ( lopinavir / ritonavir ) for Treatment-Experienced Patients” View full resource at abbott.com
Most Recently Shared on April 28, 2010 at 4:18 pm By:
eyeonfda Pharma and Health Lawyer
Abbott Gets FDA Approval for 1xDaily Dosing of Kaletra® ( lopinavir / ritonavir ) for Treatment-Experienced HIV http://ow.ly/1EgGB
FDA MedWatch - Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies - Drugs.com MedNews
drugs.com — “Kaletra (lopinavir ritonavir) Label Change - Serious Health Problems in Premature Babies AUDIENCE Infectious Disease ISSUE FDA notified healthcare professionals” View full resource at drugs.com
Most Recently Shared on March 9, 2011 at 3:12 pm By:
Drugs and Devices OW OW Health
FDA MedWatch - Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies: ... http://bit.ly/h5qnCf #drug
Kaletra (lopinavir) may cause adrenal problems in newborns - latimes.com
latimes.com — “Kaletra, a combination of the AIDS drugs lopinavir and ritonavir, may cause adrenal problems in newborn infants of HIV-positive mothers” View full resource at latimes.com
Most Recently Shared on July 6, 2011 at 7:02 pm By:
LA Times Health News Health News
Anti-HIV drug Kaletra can cause adrenal problems in newborns http://lat.ms/rsvhly
Oncology News & Articles - MDLinx - Glioma Ritonavir on #MDlinx
mdlinx.com — “Oncology News & Articles - MDLinx - Glioma Ritonavir on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 9, 2010 at 5:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas: Journ... http://bit.ly/bvwUHF #oncology
Infectious Disease Medical Article | Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
mdlinx.com — “Infectious Disease Medical Article: Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure” View full resource at mdlinx.com
Most Recently Shared on March 14, 2012 at 10:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who expe... http://t.co/EQwW1mqV #ID
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
OrganizedWisdom HIV
Organizing HIV resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
OrganizedWisdom HIV
Organizing HIV resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
